Spots Global Cancer Trial Database for ganglioglioma

Every month we try and update this database with for ganglioglioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors	NCT02684058	Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Ipon...	Dabrafenib trametinib Carboplatin Vincristine	12 Months - 17 Years	Novartis
Pediatric Long-Term Follow-up and Rollover Study	NCT03975829	Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Lipo... Neurofibromatos...	dabrafenib trametinib	1 Year -	Novartis
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma	NCT04923126	Low-Grade Gliom... Recurrent Low-G... Progressive Low...	Mirdametinib	2 Years - 24 Years	St. Jude Children's Research Hospital
Pediatric Long-Term Follow-up and Rollover Study	NCT03975829	Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Lipo... Neurofibromatos...	dabrafenib trametinib	1 Year -	Novartis
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors	NCT02684058	Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Ipon...	Dabrafenib trametinib Carboplatin Vincristine	12 Months - 17 Years	Novartis
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology	NCT04648462	Astrocytoma Ependymoma Ganglioglioma Oligodendroglio... Optic Nerve Gli... Meningioma Nerve Sheath Ne... Adenoma Craniopharyngio... Hemangiopericyt... Germinoma Neurilemmoma	ProTRAIT	18 Years -	Maastricht Radiation Oncology
Antineoplaston Therapy in Treating Children With Brain Tumors	NCT00003458	Childhood Brain...	Antineoplaston ...	6 Months - 18 Years	Burzynski Research Institute
Pediatric Long-Term Follow-up and Rollover Study	NCT03975829	Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Lipo... Neurofibromatos...	dabrafenib trametinib	1 Year -	Novartis
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma	NCT04065776	Glioma Pilocytic Astro... Pilomyxoid Astr... Pleomorphic Xan... Ganglioglioma Optic Pathway G... Diffuse Astrocy...	Hippocampal-avo...	6 Years - 21 Years	St. Jude Children's Research Hospital
Social Determinants of Health in Glioblastoma Population	NCT03900689	Glioma Astrocytoma Oligodendroglio... Ependymoma Ganglioglioma Pleomorphic Xan...	Part 1 Survey G... Part 2 Focus Gr...	18 Years -	Wake Forest University Health Sciences
Antineoplaston Therapy in Treating Children With Brain Tumors	NCT00003458	Childhood Brain...	Antineoplaston ...	6 Months - 18 Years	Burzynski Research Institute
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology	NCT04648462	Astrocytoma Ependymoma Ganglioglioma Oligodendroglio... Optic Nerve Gli... Meningioma Nerve Sheath Ne... Adenoma Craniopharyngio... Hemangiopericyt... Germinoma Neurilemmoma	ProTRAIT	18 Years -	Maastricht Radiation Oncology
Social Determinants of Health in Glioblastoma Population	NCT03900689	Glioma Astrocytoma Oligodendroglio... Ependymoma Ganglioglioma Pleomorphic Xan...	Part 1 Survey G... Part 2 Focus Gr...	18 Years -	Wake Forest University Health Sciences

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: